U.S. Markets close in 4 hrs 10 mins

Research Report Identifies Prudential Financial, Second Sight Medical Products, Acushnet, Repligen, Scorpio Tankers, and Aethlon Medical with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

NEW YORK, Nov. 12, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Prudential Financial, Inc. (PRU), Second Sight Medical Products, Inc. (EYES), Acushnet Holdings Corp. (GOLF), Repligen Corporation (RGEN), Scorpio Tankers Inc. (STNG), and Aethlon Medical, Inc. (AEMD), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

PRU DOWNLOAD: http://MarketSourceResearch.com/register/?so=PRU
EYES DOWNLOAD: http://MarketSourceResearch.com/register/?so=EYES
GOLF DOWNLOAD: http://MarketSourceResearch.com/register/?so=GOLF
RGEN DOWNLOAD: http://MarketSourceResearch.com/register/?so=RGEN
STNG DOWNLOAD: http://MarketSourceResearch.com/register/?so=STNG
AEMD DOWNLOAD: http://MarketSourceResearch.com/register/?so=AEMD

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine Prudential Financial, Inc. (PRU), Second Sight Medical Products, Inc. (EYES), Acushnet Holdings Corp. (GOLF), Repligen Corporation (RGEN), Scorpio Tankers Inc. (STNG), and Aethlon Medical, Inc. (AEMD) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed November 8th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

PRUDENTIAL FINANCIAL, INC. (PRU) REPORT OVERVIEW

Prudential Financial's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Prudential Financial reported revenue of $16,148.00MM vs $16,313.00MM (down 1.01%) and analysts estimated basic earnings per share $4.02 vs $5.19 (down 22.46%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Prudential Financial reported revenue of $59,689.00MM vs $58,779.00MM (up 1.55%) and analysts estimated basic earnings per share $18.19 vs $9.85 (up 84.67%). Analysts expect earnings to be released on February 6th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $2.69. The estimated EPS forecast for the next fiscal year is $13.06 and is expected to report on February 6th, 2019.

To read the full Prudential Financial, Inc. (PRU) report, download it here: http://MarketSourceResearch.com/register/?so=PRU

-----------------------------------------

SECOND SIGHT MEDICAL PRODUCTS, INC. (EYES) REPORT OVERVIEW

Second Sight Medical Products' Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Second Sight Medical Products reported revenue of $1.91MM vs $2.24MM (down 14.71%) and analysts estimated basic earnings per share -$0.12 vs -$0.12. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Second Sight Medical Products reported revenue of $7.96MM vs $3.99MM (up 99.85%) and analysts estimated basic earnings per share -$0.53 vs -$0.84. Analysts expect earnings to be released on March 6th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was -$0.16. The estimated EPS forecast for the next fiscal year is -$0.50 and is expected to report on March 6th, 2019.

To read the full Second Sight Medical Products, Inc. (EYES) report, download it here: http://MarketSourceResearch.com/register/?so=EYES

-----------------------------------------

ACUSHNET HOLDINGS CORP. (GOLF) REPORT OVERVIEW

Acushnet's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Acushnet reported revenue of $370.43MM vs $347.26MM (up 6.67%) and analysts estimated basic earnings per share $0.09 vs $0.13 (down 30.77%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Acushnet reported revenue of $1,560.26MM vs $1,572.28MM (down 0.76%) and analysts estimated basic earnings per share $1.24 vs $0.74 (up 67.57%). Analysts expect earnings to be released on March 6th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $0.16. The estimated EPS forecast for the next fiscal year is $1.64 and is expected to report on March 6th, 2019.

To read the full Acushnet Holdings Corp. (GOLF) report, download it here: http://MarketSourceResearch.com/register/?so=GOLF

-----------------------------------------

REPLIGEN CORPORATION (RGEN) REPORT OVERVIEW

Repligen's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Repligen reported revenue of $49.53MM vs $36.58MM (up 35.40%) and basic earnings per share $0.11 vs $0.11 (unchanged). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Repligen reported revenue of $141.24MM vs $104.54MM (up 35.10%) and analysts estimated basic earnings per share $0.74 vs $0.35 (up 111.43%). Analysts expect earnings to be released on February 28th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.20. The estimated EPS forecast for the next fiscal year is $0.85 and is expected to report on February 28th, 2019.

To read the full Repligen Corporation (RGEN) report, download it here: http://MarketSourceResearch.com/register/?so=RGEN

-----------------------------------------

SCORPIO TANKERS INC. (STNG) REPORT OVERVIEW

Scorpio Tankers' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Scorpio Tankers reported revenue of $119.28MM vs $123.12MM (down 3.12%) and analysts estimated basic earnings per share -$0.23 vs -$0.16. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Scorpio Tankers reported revenue of $512.73MM vs $522.75MM (down 1.92%) and analysts estimated basic earnings per share -$0.73 vs -$0.15. Analysts expect earnings to be released on February 13th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.14. The estimated EPS forecast for the next fiscal year is -$0.09 and is expected to report on February 13th, 2019.

To read the full Scorpio Tankers Inc. (STNG) report, download it here: http://MarketSourceResearch.com/register/?so=STNG

-----------------------------------------

AETHLON MEDICAL, INC. (AEMD) REPORT OVERVIEW

Aethlon Medical's Recent Financial Performance

For the twelve months ended March 31st, 2018 vs March 31st, 2017, Aethlon Medical reported revenue of $0.15MM vs $0.39MM (down 61.85%) and analysts estimated basic earnings per share -$0.46 vs -$0.94. Analysts expect earnings to be released on February 7th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.08. The estimated EPS forecast for the next fiscal year is -$0.30 and is expected to report on June 14th, 2019.

To read the full Aethlon Medical, Inc. (AEMD) report, download it here: http://MarketSourceResearch.com/register/?so=AEMD

-----------------------------------------

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that’s ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Hugo Moreau, Media Department
Office: +1 (704) 343-6361
E-mail: media@MarketSourceResearch.com

© 2018 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.